Selective Condensate Modulator Screening Using Perturbation Scores
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional disease research and therapeutic drug discovery face limitations due to the complexity of in vivo systems and incomplete understanding of cellular pathways, leading to a shortage of new therapeutic drugs, and existing methods for modulating biological condensates can cause undesirable drug toxicity and off-target effects.
Innovation Solution
A method is provided to identify stimuli for selective condensate modulation by measuring marker perturbation scores and global condensate perturbation scores in cellular compositions, allowing for the identification of selective condensate modulators using marker and global condensate perturbation scores.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemical entities are used to dissolve or prevent formation of biological condensates, then condensate modulation is achieved, but drug toxicity and off-target properties increase
Solution Approach 1:
The patent applies local quality by developing condensate-specific modulation strategies where chemical entities are designed to interact with specific condensate components or markers rather than indiscriminately affecting all condensates. This selective approach allows effective condensate modulation while minimizing off-target effects and toxicity by targeting only the relevant biological condensates associated with disease pathology.
Solution Approach 2:
The patent employs parameter changes by utilizing high-content imaging and quantitative analysis to measure specific parameters of condensates (such as size, number, distribution, and marker association) before and after treatment. This enables precise determination of condensate modulation effects and helps identify chemical entities that achieve the desired therapeutic effect with minimal toxicity by optimizing the modulation parameters.
2Device complexity
If conventional single target approach is used for drug discovery, then individual biomolecule targeting is simplified, but therapeutic drug shortage occurs due to system complexity
Solution Approach 1:
The patent applies universality by developing a multi-functional drug discovery platform that combines high-content imaging, automated image analysis, and quantitative data processing into a single integrated system. This platform can simultaneously evaluate multiple chemical entities against multiple condensate markers and parameters, enabling comprehensive screening that addresses system complexity while maintaining process efficiency and increasing therapeutic drug output.
Solution Approach 2:
The patent introduces an intermediary layer of quantitative image analysis and data processing between the chemical entities and the final therapeutic evaluation. This intermediary system automatically measures condensate parameters, calculates perturbation scores, and ranks chemical entities, thereby simplifying the complex evaluation process while enabling systematic identification of multiple therapeutic candidates simultaneously.
3Adaptability or versatility
If indiscriminate condensate dissolution is achieved, then broad condensate impact is obtained, but selectivity for specific condensate types is lost
Solution Approach 1:
The patent applies segmentation by dividing the condensate modulation assessment into distinct components: different condensate types are evaluated separately using type-specific markers, and each condensate's response to chemical entities is measured independently. This segmented approach enables both broad impact assessment across multiple condensate types and precise selectivity determination for each specific condensate type through quantitative comparison.
Data Source
AI summary
The present application provides, in some aspects, methods of identifying a stimulus for a condensate modulatory characteristic for one or more condensate types, such as to identify a selective condensate modulator. In other aspects, also provided herein are kits and systems.